Baxter International | BAX - Fremdkapital





Fremdkapital Veränderung Datum
Abbott USD 29.64B 19.74B 2026-03
AngioDynamics USD 5.6M 100K 2025-09
Artivion USD 363.42M 148.07M 2026-06
AtriCure USD 61M 0 2026-06
Baxter International USD 8.62B 6M 2026-06
Becton, Dickinson and Co. USD 13.51B 1.2B 2026-06
Boston Scientific USD 10.86B 148M 2026-03
Cooper Companies USD 1.86B 17.7M 2026-03
Dexcom USD 1.3B 200K 2026-06
Edwards Lifesciences USD 598.7M 1.3M 2026-06
Fresenius EUR 9.55B 1.24B 2026-06
Globus Medical USD 398K 38K 2026-03
Halozyme Therapeutics USD 1.94B 1.79M 2026-06
ICU Medical USD 1.21B 49.38M 2026-06
Inogen USD 0 0 2022-06
Insulet USD 929.5M 0 2026-06
Integra LifeSciences USD 1.83B 2.05M 2026-06
Intuitive Surgical USD 0 0 2025-03
J&J USD 37.34B 183M 2026-06
Laboratory Of America USD 5.92B 23.3M 2026-06
Medtronic USD 26.12B 1.76B 2026-03
Merit Medical Systems USD 736.26M 1.1M 2026-06
Quest Diagnostics USD 5.63B 477M 2026-06
Smith & Nephew USD 3.21B 85M 2026-06
Stryker USD 14.19B 32M 2026-06
Tandem Diabetes Care USD 602.58M 809K 2026-06
Teleflex USD 2.72B 206.24M 2026-06
Terumo JPY 209.52B 109.61B 2026-06
Zimmer Biomet Holdings USD 6.28B 17.6M 2026-06